Validation of COMPAT-SF Spanish Translation

Methodist Health System100 enrolled

Overview

Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Chronic Pancreatitis

Interventions

QuestionnairesBEHAVIORAL

Administer translated COMPAT-SF questionnaires to Spanish-speaking CP patients

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years or older in age * Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months * Able to read and understand the study information in Spanish * Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study * Subject is willing and able to comply with the scheduled questionnaires Exclusion Criteria: * Subjects who do not meet the criteria in section 4.1

Locations (1)

Methodist Dallas Medical Center- Clinical Research Institute

Dallas, Texas, United States

RECRUITING

Outcomes

Primary Outcomes

Face validity:

Patient-reported feedback through a questionnaire concerning the feasibility of the translated COMPAT-SF questionnaire

Time frame: through study completion, up to 18 months

Central Contacts

Jeff Wilson

CONTACT

2149471279 JeffreyWilson@mhd.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.